Highest risk: Visual Distraction
Highest risk: Visual Distraction · FDA letter on file
Highest risk: Visual Distraction · FDA letter on file
Highest risk: Visual Distraction · FDA letter on file
Highest risk: Visual Distraction
New FDA enforcement letter incorporated (Feb 6, 2026: TREMFYA, Vonjo). 4 violation patterns detected.
You're receiving this because you're subscribed to Video Content Compliance Monitor alerts. Manage preferences